# Beyond the Apex: A Case Series of Mid-ventricular Takotsubo Cardiomyopathy

**Authors:** Fnu Parul, Karuna Rayamajhi, Rohan Kumar, Akhil Gaderaju, Mahmoud Khairy, Appa Bandi

PMC · DOI: 10.7759/cureus.102063 · Cureus · 2026-01-22

## TL;DR

This paper presents two cases of mid-ventricular Takotsubo cardiomyopathy triggered by physical stressors, emphasizing the importance of recognizing atypical presentations for timely diagnosis and treatment.

## Contribution

The novelty lies in highlighting mid-ventricular TCM as an atypical variant and showcasing its clinical presentation and management in real-world cases.

## Key findings

- Mid-ventricular TCM can present with acute cardiac dysfunction and mimic acute coronary syndromes.
- Prompt diagnosis and treatment with beta-blockers and ARBs led to full recovery in both cases.
- Recognition of atypical TCM variants is crucial for preventing misdiagnosis and recurrence.

## Abstract

Takotsubo cardiomyopathy (TCM), also known as stress-induced cardiomyopathy, is characterized by transient, reversible left ventricular systolic dysfunction in the absence of obstructive coronary artery disease (CAD). It can mimic acute coronary syndromes, posing diagnostic challenges that require a high index of suspicion. We present two cases of mid-ventricular TCM, each triggered by distinct acute physical stressors. The first case involves a 63-year-old male with a history of cerebrovascular accident and nicotine dependence who presented following a generalized tonic-clonic seizure. His electrocardiogram demonstrated ST-segment elevations in the inferolateral leads, and laboratory workup revealed elevated cardiac biomarkers. Coronary angiography showed mild non-obstructive CAD, while echocardiography revealed mid-ventricular regional wall motion abnormalities with an ejection fraction (EF) of 35-40%. He was treated with beta-blockers, angiotensin receptor blockers, aspirin, and statin therapy, with complete recovery of cardiac function on follow-up. The second case involves a 66-year-old female with a history of asthma, obstructive sleep apnea, and prior breast cancer who developed acute hypoxic respiratory failure following hashish inhalation. She presented with chest pain and elevated troponin levels, but without ST-segment elevation. Echocardiography showed mid-ventricular wall motion abnormalities and a reduced EF of 30-35%, while coronary angiography demonstrated no significant obstructive disease. Her presentation was consistent with mid-ventricular TCM secondary to acute hypoxemia and physical stress. These cases highlight the diagnostic variability and clinical spectrum of TCM, emphasizing the need for early recognition of atypical variants. Awareness of mid-ventricular presentations is essential for prompt diagnosis, appropriate management, and prevention of recurrence in patients presenting with acute cardiac dysfunction without significant coronary obstruction.

## Linked entities

- **Chemicals:** nicotine (PubChem CID 942), hashish (PubChem CID 16078)
- **Diseases:** Takotsubo cardiomyopathy (MONDO:0019018), cerebrovascular accident (MONDO:0005098), asthma (MONDO:0004979), obstructive sleep apnea (MONDO:0007147), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha) [NCBI Gene 5286] {aka CPK, OCSKD, PI3-K-C2(ALPHA), PI3-K-C2A, PI3K-C2-alpha, PI3K-C2alpha}
- **Diseases:** ischemic coronary (MESH:D003323), pulmonary embolism (MESH:D011655), hyperkinetic (MESH:D006948), pheochromocytoma (MESH:D010673), ischemia (MESH:D007511), obstructive (MESH:D000402), stenosis (MESH:D003251), seizure (MESH:D012640), emphysematous (MESH:D041882), hypoxemia (MESH:D000860), ST-elevation myocardial infarction (MESH:D000072657), wheezing (MESH:D012135), hypoxic (MESH:D002534), breast cancer (MESH:D001943), calcium (MESH:D002128), sinus tachycardia (MESH:D013616), left ventricular systolic dysfunction (MESH:D018487), obstructive sleep apnea (MESH:D020181), hypoxemic (MESH:D012131), myocarditis (MESH:D009205), CAD (MESH:D003324), acidemia (MESH:C537358), cerebrovascular accident (MESH:D020521), cardiac dysfunction (MESH:D006331), cardiomyopathy (MESH:D009202), chest pain (MESH:D002637), plaque rupture (MESH:D012421), ischemic (MESH:D002545), acute myocardial infarction (MESH:D009203), neurological or psychiatric disorders (MESH:D001523), RWMAs (MESH:D009041), cardiogenic shock (MESH:D012770), shortness of breath (MESH:D004417), leukocytosis (MESH:D007964), asthma (MESH:D001249), tachypnea (MESH:D059246), calcium overload (MESH:D019190), microvascular dysfunction (MESH:D017566), fibrosis (MESH:D005355), abnormalities (MESH:D000014), nicotine dependence (MESH:D014029), ACS (MESH:D054058), coronary obstruction (MESH:D000088442), (takotsubo) cardiomyopathy (MESH:D054549), coronary disease (MESH:D003327), obstructive disease (MESH:D001157), hypertensive (MESH:D006973), LVOT obstruction (MESH:D000092242)
- **Chemicals:** heparin (MESH:D006493), aspirin (MESH:D001241), gadolinium (MESH:D005682), magnesium sulfate (MESH:D008278), lactate (MESH:D019344), catecholamine (MESH:D002395), LAMA (-), oxygen (MESH:D010100), ammonia (MESH:D000641)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926683/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926683/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926683/full.md

---
Source: https://tomesphere.com/paper/PMC12926683